this year


  1. Homologous recombination in human iPS and ES cells for use in gene correction therapy.
    Nakayama M. (2010)
    Drug Discov Today. 15(5-6): 198-202.

  2. Eliminating target cells by inducing apoptosis-related factors using hTERT promoter.
    Takashina T, Nakayama M. (2010)
    Open Biotechnol J. 4: 1-7.

  3. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Kim HG, Ahn JW, Kurth I, Ullmann R, Kim HT, Kulharya A, Ha KS, Itokawa Y, Meliciani I, Wenzel W, Lee D, Rosenberger G, Ozata M, Bick DP, Sherins RJ, Nagase T, Tekin M, Kim SH, Kim CH, Ropers HH, Gusella JF, Kalscheuer V, Choi CY, Layman LC. (2010)
    Am J Hum Genet. 87(4): 465-79.

  4. Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex.
    Lu B, Zhang Q, Wang H, Wang Y, Nakayama M, Ren D. (2010)
    Neuron. 68(3): 488-99.

  5. Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: Confounding role of the inhibitory FcgammaRIIb.
    Masuda K, Mori H, Ohara O, Nakayama M, Wang JY, Burrows PD. (2010)
    Cell Immunol. 266(1): 24-31.